Showing results (1-10 of 141) with videos related to
Sort By:
Pageof 15
Cancer Treatment and Research Communications|July 14, 2022
Eponyms in Malignant HematologyDanielle Brazel, Priyanka Kumar, David J Benjamin, et al.Cancer Treatment and Research Communications|January 22, 2022
Eponyms in medical oncologyPriyanka Kumar, Danielle Brazel, David J Benjamin, et al.Journal of Gastrointestinal Oncology|January 24, 2022
Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignanciesShannon Zhang, Danielle Brazel, Priyanka Kumar, et al.JAMA Network Open|January 5, 2023
Genomic Alterations and Tumor Mutation Burden in Merkel Cell CarcinomaDanielle Brazel, Priyanka Kumar, Hung Doan, et al.Med (New York, N.Y.)|August 10, 2024
Checkmate 77T: Perioperative chemoimmunotherapy outperforms in early-stage NSCLCDanielle Brazel, Misako NagasakaTargeted Oncology|May 13, 2024
Divarasib in the Evolving Landscape of KRAS G12C Inhibitors for NSCLCDanielle Brazel, Misako NagasakaRespiratory Research|October 25, 2023
The development of amivantamab for the treatment of non-small cell lung cancerDanielle Brazel, Misako NagasakaCancers|February 13, 2026
Uveal Melanoma: Biology, Prognostication, and Emerging Therapies to Outsmart an Immune-Cold MelanomaDanielle Brazel, Elizabeth BuchbinderLung Cancer (Auckland, N.Z.)|December 9, 2021
Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung CancerDanielle Brazel, Misako NagasakaLung Cancer (Auckland, N.Z.)|May 26, 2022
Deconstructing ADAURA. It is Not Yet Time to Forgo Platinum-based Adjuvant Chemotherapy in Resected Early Stage (IB-IIIA) EGFR-mutant NSCLCDanielle Brazel, Misako NagasakaPageof 15